ライフサイエンスコーパス: transcription-mediated amplification

1 s and retrospectively tested for DENV RNA by transcription-mediated amplification.

2 -transcription polymerase chain reaction and transcription-mediated amplification.

3 TV was detected by transcription-mediated amplification.

4 rine was retrospectively tested for MG using transcription-mediated amplification.

5 lly positive for M. genitalium by commercial transcription-mediated amplification.

6 luded urine testing for trichomoniasis using transcription-mediated amplification.

7 he Molecular Systems, Branchburg, N.J.]; and transcription-mediated amplification, [Amplified CT Assa

8 ED Chlamydia Trachomatis Assay (AMP CT) uses transcription-mediated amplification and hybridization p

9 The assay utilizes target capture, transcription-mediated amplification, and acridinium est

10 itivities for the polymerase chain reaction, transcription-mediated amplification, and strand displac

11 fols triplex ZIKV, CHIKV, and DENV real-time transcription mediated amplification assay to estimate p

12 N. gonorrhoeae, the Gen-Probe Aptima Combo 2 transcription-mediated amplification assay (TMA), the BD

13 Fifty-two percent and 47% used a transcription-mediated amplification assay for HIV and H

14 suggested that a research-use-only real-time transcription-mediated amplification assay for Treponema

15 Subsequently, a transcription-mediated amplification assay targeting rib

16 e participating centers was also tested by a transcription-mediated amplification assay which was use

17 Transcription-mediated amplification assays were used to

18 lar amplified laboratory-developed test) and transcription-mediated amplification-based rRNA target s

19 outpatient physician group were subjected to transcription-mediated amplification-based Trichomonas v

20 ultiple-site infection status standard), and transcription-mediated amplification (for C. trachomatis

21 (HCV) RNA in human serum or plasma based on transcription-mediated amplification (HCV TMA).

22 A transcription-mediated amplification method for detectio

23 mposite reference method consisting of three transcription-mediated amplification NAATs targeting uni

24 e performance of two new in vitro diagnostic transcription-mediated amplification nucleic acid amplif

25 ombo 2 assay, a multiplex assay based on the transcription-mediated amplification reaction, for the s

26 Research-use-only Treponema pallidum transcription-mediated amplification (RUO T. pallidum TM

27 the Procleix HIV-1/HCV Assay, which utilizes transcription-mediated amplification technology to simul

28 a trachomatis and Neisseria gonorrhoeae by a transcription-mediated amplification test (AC2; Aptima C

29 s the additional value of an investigational transcription-mediated amplification test for TP (TP-TMA

30 probe for Gardnerella vaginalis, the Hologic transcription-mediated amplification (TMA) analyte-speci

31 nfluenza RNA amplification assays, including transcription-mediated amplification (TMA) and 2 reverse

32 Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-s

33 AMP CT uses transcription-mediated amplification (TMA) and hybridiza

34 The Bayer transcription-mediated amplification (TMA) and the Roche

35 lular HIV RNA levels were measured using the transcription-mediated amplification (TMA) assay (estima

36 we compared a newly developed research-only transcription-mediated amplification (TMA) assay (Gen-Pr

37 y to the Gen-Probe Aptima T. vaginalis (ATV) transcription-mediated amplification (TMA) assay for det

38 lected from each subject were tested using a transcription-mediated amplification (TMA) assay for M.

39 e characteristics of a new research-use-only transcription-mediated amplification (TMA) assay for the

40 Trichomonas vaginalis detection, Gen-Probe's transcription-mediated amplification (TMA) assay for Tri

41 The Siemens VERSANT transcription-mediated amplification (TMA) assay is extr

42 mental 23S rRNA Treponema pallidum real-time transcription-mediated amplification (TMA) assay perform

43 tive in 2 of 23 replicates using a sensitive transcription-mediated amplification (TMA) assay, and es

44 neiro, Brazil, were tested for DENV RNA by a transcription-mediated amplification (TMA) assay, with D

45 olymerase chain reaction (PCR) assays, and a transcription-mediated amplification (TMA) assay.

46 Transcription-mediated amplification (TMA) enhances dete

47 roughput molecular diagnostic test that uses transcription-mediated amplification (TMA) for the detec

48 oplasma genitalium assay, an investigational transcription-mediated amplification (TMA) NAAT for the

49 roughput method for detecting ZIKV RNA using transcription-mediated amplification (TMA) technology.

50 was first determined with a highly sensitive transcription-mediated amplification (TMA) test performe

51 analytical and clinical performance of three transcription-mediated amplification (TMA) tests for M.

52 s Salinas Valley (Monterey County) receiving transcription-mediated amplification (TMA) tests for SAR

53 strand displacement amplification (SDA) and transcription-mediated amplification (TMA) to detect C.

54 detection of hepatitis C virus (HCV) RNA by transcription-mediated amplification (TMA) was conducted

55 ing positive for M. genitalium by commercial transcription-mediated amplification (TMA) were initiall

56 arget capture-based sample preparation, (ii) transcription-mediated amplification (TMA), and (iii) hy

57 ae, and Trichomonas vaginalis via commercial transcription-mediated amplification (TMA), residual mat

58 using culture and commercial NAATs employing transcription-mediated amplification (TMA), strand displ

59 increased accuracy of Trichomonas vaginalis transcription-mediated amplification (TMA)-based analyte

60 A retrospective 3-year investigation of transcription-mediated amplification (TMA)-based urethra

61 showed 97.1% correlation with RNA-based PCR (transcription-mediated amplification [TMA]) for positive